Status:
COMPLETED
Meteorin-like Levels in Individuals With Periodontitis
Lead Sponsor:
Istanbul Saglik Bilimleri University
Conditions:
Periodontitis
Gingivitis
Eligibility:
All Genders
18-70 years
Brief Summary
Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl is highly expressed from the oral mucosa t...
Detailed Description
Periodontitis is a destructive chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then...
Eligibility Criteria
Inclusion
- systemically healthy
- individuals who does not have a disease under treatment,
- individuals without regular systemic medication
Exclusion
- smoking
- receiving periodontal treatment in the last 6 months
- pregnancy
- menopausal or menstrual period
Key Trial Info
Start Date :
September 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 3 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04402996
Start Date
September 23 2020
End Date
March 3 2021
Last Update
April 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebru Sağlam
Istanbul, Eyalet/Yerleşke, Turkey (Türkiye), 34668